First-line pembrolizumab for lung cancer in a Spanish real-world study.

被引：0
|
作者：
Burgos, Amparo
Calleja, Teresa
Ibanez, Cristina
Maria Valencia, Carmen
Orallo, Claudia
Carlos Titos, Jose
Conde, David
Diaz, Sacramento
Matilla, Belen
Lizeaga, Garbine
Sanchez, Carmen
Marin Pozo, Juan Francisco
Jimenez, Silvia
Jimenez, Inmaculada
Diez, Raul
Garrido, Margarita
Larrosa, Maria
Jose Martinez, Maria
Moreno, Estela
Garcia Campelo, Rosario
机构：
[1] Hosp Univ Dr Balmis Alicante ISABIAL, Alicante, Spain
[2] Hosp Univ La Coruna, La Coruna, Spain
[3] Catalan Inst Oncol Hosp, Oncol Pharm Dept, Lhospitalet De Llobregat, Spain
[4] Hosp Univ Marques de Valdecilla, Santander, Spain
[5] Hosp Univ Asturias, Oviedo, Spain
[6] Hosp Univ Morales Meseguer, Murcia, Spain
[7] Hosp Mar, Barcelona, Spain
[8] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
[9] Complejo Asistencial Univ Leon, Leon, Spain
[10] Hosp Univ Donostia, San Sebastian, Spain
[11] Hosp Univ Virgen de las Nieves, Granada, Spain
[12] Hosp Univ Jaen, Jaen, Spain
[13] Hosp Univ Salamanca, Salamanca, Spain
[14] Hosp Univ Elche, Elche, Spain
[15] Hosp Univ Getafe, Getafe, Spain
[16] Hosp Virgen Victoria, Malaga, Spain
[17] Hosp Univ Valle Hebron, Barcelona, Spain
[18] Hosp Univ Puerta Mar, Cadiz, Spain
[19] Hosp St Pau & Santa Creu Barcelona, Barcelona, Spain
[20] Hosp Univ A Coruna, La Coruna, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23268
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness of first-line maintenance olaparib in women with BRCA-mutated advanced ovarian cancer: US retrospective cohort study.
    Eskander, Ramez Nassef
    Alam, Naufil
    Long, Grainne H.
    Ozgoren, Ozan
    Ambler, Will
    Volpe, Stephanie
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort
    Tafenzi, H. A.
    Takniouine, Y. Ait
    Haag, E. K.
    Abdillahi, B. D.
    Choulli, F.
    Baladi, A.
    Essadi, I.
    Belbaraka, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S153 - S153
  • [23] Letter Re: Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
    Zhu, Hao
    Wang, Fa-Lin
    Liu, Jia-Ren
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [24] Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
    Engel-Nitz, Nicole M.
    Johnson, Michael P.
    Bunner, Scott H.
    Ryan, Kellie J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (06): : 729 - 740
  • [25] Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small cell lung cancer
    Hsu, Grace G.
    MacKay, Eric
    Scheuer, Nicolas
    Ramagopalan, Sreeram, V
    IMMUNOTHERAPY, 2021, 13 (18) : 1453 - 1456
  • [26] First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
    Moliner, Laura
    Zellweger, Nuria
    Schmid, Sabine
    Bertschinger, Martina
    Waibel, Christine
    Cerciello, Ferdinando
    Froesch, Patrizia
    Mark, Michael
    Bettini, Adrienne
    Blum, Veronika
    Holer, Lisa
    Hayoz, Stefanie
    Fruh, Martin
    Ahmed, Samreen
    Haeuptle, Pirmin
    Bhagani, Shradha
    Steele, Nicola
    Gray, Hannah-Leigh
    Robinson, Stephen D.
    Davidson, Michael
    Cox, Samantha
    Khalid, Taha
    Geldart, Tom R.
    Nolan, Luke
    Scott, Deborah C.
    Hennah, Lindsay
    Newsom-Davis, Tom
    Rathbone, Emma
    Handforth, Catherine
    Denton, Arshi
    Merchant, Shairoz
    Blackhall, Fiona
    Mauti, Laetitia A.
    Califano, Raffaele
    Rothschild, Sacha I.
    JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (01):
  • [27] First-Line Pembrolizumab-Combination Therapy for Advanced Squamous NSCLC: Real-World Outcomes at US Oncology Practices
    Liu, S.
    Rai, P.
    Wang, D.
    Hu, X.
    Schwarzenberger, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S383 - S384
  • [28] REAL-WORLD USE OF PEMBROLIZUMAB COMBINATION REGIMENS IN FIRST-LINE RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Black, Christopher
    Wang, Liya
    Ramakrishnan, Karthik
    Goto, Daisuke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A832 - A832
  • [29] Real-world treatment modification of first-line axitinib plus pembrolizumab in patients with metastatic renal cell carcinoma (mRCC)
    Zakharia, Y.
    Thomaidou, D.
    Li, B.
    Siu, G.
    Levin, R.
    Vlahiotis, A.
    Zanotti, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1424
  • [30] The Safety and Efficacy of Cadonilimab in the First-Line Treatment of Recurrent or Metastatic Cervical Cancer: A Retrospective, Real-World Study
    Jin, G.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E693 - E693
12345